Inventor · disambiguated record
Lukasz Kielpinski
Also filed as: KIELPINSKI LUKASZ · KIELPINSKI LUKASZ J
2 granted patents·12 pending applications·0 citations·filing 2017–2025
23Inventor score
Top patents by PatentIndex Score
14 records- 0163US2024294915A1Oligonucleotides for Modulating Apolipoprotein E4 ExpressionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0259US2024376474A1Antisense oligonucleotides for modulating tmem106b expressionGENENTECH INC·Filed 2024·Application pending·0 cites
- 0356US2023313189A1Complement component 4 inhibitors for treating neurological diseases, and related compositons, systems and methods of using sameGENENTECH INC·Filed 2022·Application pending·0 cites
- 0456US2023399643A1Complement component c1s inhibitors for treating a neurological disease, and related compositions, systems and methods of using sameGENENTECH INC·Filed 2022·Application pending·0 cites
- 0556US2023323362A1Complement component c1r inhibitors for treating a neurological disease, and related compositions, systems and methods of using sameGENENTECH INC·Filed 2022·Application pending·0 cites
- 0654US2021269851A1Massively parallel discovery methods for oligonucleotide therapeuticsROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 0754US2022002796A1Quality control of lna oligonucleotide therapeutics using massively parallel sequencingROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 0854US2021071247A1Massively parallel discovery methods for oligonucleotide therapeuticsROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 0953US12421552B2MicroRNA-134 biomarkerROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Granted Sep 23, 2025·0 cites·10 claims
- 1053US11485975B2Oligonucleotides for modulating TMEM106B expressionGENENTECH INC·Filed 2020·Granted Nov 1, 2022·0 cites·30 claims
- 1153US2022177883A1Antisense Oligonucleotides Targeting ATXN3HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1250US2023054720A1Antisense Oligonucleotides Targeting ATXN3HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1345US2025376684A1Threose nucleic acid antisense oligonucleotides and methods thereofHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1436US2019284621A1Therapeutic oligonucleotides capture and detectionROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lukasz Kielpinski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →